These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21157026)

  • 61. Effect of long-term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET.
    Nordberg A
    Acta Neurol Scand Suppl; 1993; 149():62-5. PubMed ID: 8128843
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quantitative PET analysis of regional cerebral blood flow and glucose and oxygen metabolism in response to fenfluramine in living porcine brain.
    Smith DF; Poulsen PH; Ishizu K; Sakoh M; Hansen SB; Gee AD; Bender D; Gjedde A
    J Neurosci Methods; 1998 Dec; 86(1):17-23. PubMed ID: 9894782
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Brain metabolism and blood flow during development and aging of the Fischer-344 rat.
    Rapoport SI; London ED; Takei H
    Exp Brain Res; 1982; Suppl 5():86-101. PubMed ID: 7151925
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study.
    Parks RW; Becker RE; Rippey RF; Gilbert DG; Matthews JR; Kabatay E; Young CS; Vohs C; Danz V; Keim P; Collins GT; Zigler SS; Urycki PG
    Neuropsychol Rev; 1996 Jun; 6(2):61-79. PubMed ID: 8976498
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential effects of acetylcholinesterase inhibitors on clinical responses and cerebral blood flow changes in patients with Alzheimer's disease: a 12-month, randomized, and open-label trial.
    Shimizu S; Kanetaka H; Hirose D; Sakurai H; Hanyu H
    Dement Geriatr Cogn Dis Extra; 2015; 5(1):135-46. PubMed ID: 25999980
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease.
    Eriksdotter Jönhagen M; Nordberg A; Amberla K; Bäckman L; Ebendal T; Meyerson B; Olson L; Seiger ; Shigeta M; Theodorsson E; Viitanen M; Winblad B; Wahlund LO
    Dement Geriatr Cogn Disord; 1998; 9(5):246-57. PubMed ID: 9701676
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Parametric in vivo brain imaging during activation to examine pathological mechanisms of functional failure in Alzheimer disease.
    Rapoport SI; Grady CL
    Int J Neurosci; 1993 May; 70(1-2):39-56. PubMed ID: 8083023
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A PET study following treatment with a pharmacological stressor, FG7142, in conscious rhesus monkeys.
    Takamatsu H; Noda A; Kurumaji A; Murakami Y; Tatsumi M; Ichise R; Nishimura S
    Brain Res; 2003 Aug; 980(2):275-80. PubMed ID: 12867268
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PET imaging in Alzheimer's disease.
    Besson JA; Crawford JR; Evans NT; Gemmell HG; Roeda D
    J R Soc Med; 1992 Apr; 85(4):231-4. PubMed ID: 1433068
    [No Abstract]   [Full Text] [Related]  

  • 70. Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG.
    Gustafson L; Edvinsson L; Dahlgren N; Hagberg B; Risberg J; Rosén I; Fernö H
    Psychopharmacology (Berl); 1987; 93(1):31-5. PubMed ID: 3114812
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Changes in electrophysiological markers of cognitive control after administration of galantamine.
    Gascoyne LE; Mullinger KJ; Robson SE; Kumar J; O'Neill GC; Palaniyappan L; Morris PG; Liddle EB; Brookes MJ; Liddle PF
    Neuroimage Clin; 2018; 20():228-235. PubMed ID: 30090697
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation.
    Heiss WD; Kessler J; Mielke R; Szelies B; Herholz K
    Dementia; 1994; 5(2):88-98. PubMed ID: 8038871
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Therapeutic effects of CDP-choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factors.
    Cacabelos R; Caamaño J; Gómez MJ; Fernández-Novoa L; Franco-Maside A; Alvarez XA
    Ann N Y Acad Sci; 1996 Jan; 777():399-403. PubMed ID: 8624120
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The potential of activation of somatostatinergic neurotransmission with FK960 in Alzheimer's disease.
    Doggrell SA
    Expert Opin Investig Drugs; 2004 Jan; 13(1):69-72. PubMed ID: 14680454
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Functional studies of new drugs for the treatment of Alzheimer's disease.
    Nordberg A
    Acta Neurol Scand Suppl; 1996; 165():137-44. PubMed ID: 8741001
    [TBL] [Abstract][Full Text] [Related]  

  • 76. RCBF in Alzheimer's disease: current issues.
    Robert P; Aubin-Brunet V; Ricq O; Bonhomme P
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():186A-187A. PubMed ID: 1498804
    [No Abstract]   [Full Text] [Related]  

  • 77. Het effect van galantamine op de ecg- geleidingstijden.
    Jobse IC; de Jonckheere RA
    Tijdschr Gerontol Geriatr; 2014 Dec; 45(6):332-7. PubMed ID: 25246067
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of the Therapeutical Effect of Matricaria Chamomilla Extract vs. Galantamine on Animal Model Memory and Behavior Using 18F-FDG PET/MRI.
    Iacob R; Palimariciuc M; Florea T; Pricope CV; Uritu CM; Tamba BI; Ionescu TM; Stolniceanu CR; Jalloul W; Dobrin RP; Hritcu L; Cioanca O; Hancianu M; Naum AG; Stefanescu C
    Curr Issues Mol Biol; 2024 May; 46(5):4506-4518. PubMed ID: 38785541
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Altered cerebral blood flow in older adults with Alzheimer's disease: a systematic review.
    Swinford CG; Risacher SL; Wu YC; Apostolova LG; Gao S; Bice PJ; Saykin AJ
    Brain Imaging Behav; 2023 Apr; 17(2):223-256. PubMed ID: 36484922
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association study identifies genetic determinants and non-genetic factors on steady-state plasma and therapeutic outcome of galantamine in mixed dementia.
    Yaowaluk T; Senanarong V; Limwongse C; Boonprasert R; Bunditvorapoom D; Kaewsutthi S; Kijsanayotin P
    Eur J Clin Pharmacol; 2022 Aug; 78(8):1249-1259. PubMed ID: 35633386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.